Global Medical REIT (NYSE: GMRE) is one of 23 public companies in the “Healthcare REITs” industry, but how does it weigh in compared to its competitors? We will compare Global Medical REIT to similar businesses based on the strength of its valuation, institutional ownership, profitability, dividends, risk, analyst recommendations and earnings.
This table compares Global Medical REIT and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Medical REIT||-19.98%||-2.86%||-1.39%|
|Global Medical REIT Competitors||33.85%||7.56%||3.70%|
Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.1%. Global Medical REIT pays out -400.0% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.5% and pay out 156.9% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.
Volatility & Risk
Global Medical REIT has a beta of -48.01, suggesting that its share price is 4,901% less volatile than the S&P 500. Comparatively, Global Medical REIT’s competitors have a beta of -2.45, suggesting that their average share price is 345% less volatile than the S&P 500.
This is a summary of current ratings and target prices for Global Medical REIT and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Medical REIT||0||1||5||0||2.83|
|Global Medical REIT Competitors||142||753||677||12||2.35|
Global Medical REIT currently has a consensus target price of $10.75, indicating a potential upside of 22.30%. As a group, “Healthcare REITs” companies have a potential upside of 7.17%. Given Global Medical REIT’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Global Medical REIT is more favorable than its competitors.
Earnings and Valuation
This table compares Global Medical REIT and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Global Medical REIT||$8.21 million||-$6.35 million||-43.95|
|Global Medical REIT Competitors||$812.10 million||$208.81 million||180.75|
Global Medical REIT’s competitors have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership
41.0% of Global Medical REIT shares are held by institutional investors. Comparatively, 83.1% of shares of all “Healthcare REITs” companies are held by institutional investors. 16.5% of Global Medical REIT shares are held by insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Global Medical REIT competitors beat Global Medical REIT on 9 of the 15 factors compared.
About Global Medical REIT
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.